[O2–17–05]: RATIONALE FOR CNP520 DOSE SELECTION FOR THE PIVOTAL CLINICAL PROGRAM IN PRECLINICAL AD. (1st July 2017) - Lopez‐Lopez, Cristina; Ufer, Mike; Rouzade‐Dominguez, Marie‐Laure; Pezous, Nicole; David, Olivier; Kolly, Carine; Tariot, Pierre; Reiman, Eric M.; Vargas, Gabriel; Lenz, Robert; Graf, Ana; Neumann, Ulf